Cover Image

IMI 2021 reports and digest: reflections on the implications for clinical practice

The International Myopia Institute's (IMI) mission is to advance research, education, and management of myopia to decrease future vision impairment and blindness associated with increasing myopia. Its approach is to bring together scientists, clinicians, policymakers, government members, and ed...

Full description

Saved in:
Bibliographic Details
Main Authors: Wolffsohn, James (Author) , Jong, Monica (Author) , Smith, Earl L., III (Author) , Resnikoff, Serge R. (Author) , Jonas, Jost B. (Author) , Logan, Nicola S. (Author) , Morgan, Ian (Author) , Sankaridurg, Padmaja (Author) , Ohno-Matsui, Kyoko (Author)
Format: Article (Journal)
Language:English
Published: April 28, 2021
In: Investigative ophthalmology & visual science
Year: 2021, Volume: 62, Issue: 5, Pages: 1-5
ISSN:1552-5783
DOI:10.1167/iovs.62.5.1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1167/iovs.62.5.1
Get full text
Author Notes:James S. Wolffsohn, Monica Jong, Earl L., III Smith, Serge R. Resnikoff, Jost B. Jonas, Nicola S. Logan, Ian Morgan, Padmaja Sankaridurg, Kyoko Ohno-Matsui
Description
Summary:The International Myopia Institute's (IMI) mission is to advance research, education, and management of myopia to decrease future vision impairment and blindness associated with increasing myopia. Its approach is to bring together scientists, clinicians, policymakers, government members, and educators into the field of myopia to stimulate collaboration and sharing of knowledge. The latest reports are on pathologic myopia, the impact of myopia, risk factors for myopia, accommodation and binocular vision in myopia development and progression, and the prevention of myopia and its progression. Together with the digest updating the 2019 International Myopia Institute white papers using the research published in the last 18 months, these evidence-based consensus white papers help to clarify the imperative for myopia control and the role of environmental modification initiatives, informing an evidence-based clinical approach. This guidance includes who to treat and when to start or stop treatment, and the advantages and limitations of different management approaches.
Item Description:Gesehen am 13.09.2021
Physical Description:Online Resource
ISSN:1552-5783
DOI:10.1167/iovs.62.5.1

Similar Items